2026-05-10 · 2026-05 / week-1
Summary: Van Elle closed at 50.70p on Friday, May 8, 2026.^price STRABAG's recommended 52.3p cash offer still leaves a 1.6p spread, or about 3.2%, even though the scheme timetable now points to shareholder meetings on Ma...
2026-05-10 · 2026-05 / week-1
Summary: UniFirst NYSE: UNF closed at $252.41 on Friday, May 8, 2026, while Cintas NASDAQ: CTAS closed at $166.97. The signed merger terms are $155.00 in cash plus 0.7720 CTAS shares for each UNF share. On the same tape,...
2026-05-10 · 2026-05 / week-1
Summary: TortoiseEcofin Gas Infra Fund NYSE: TYG traded at $46.36 on May 8, 2026 against a $47.77 NAV, leaving a 2.95% discount. The one-day price drop from $48.78 to $46.36 was sharper than the 2.5% NAV dilution implied...
2026-05-10 · 2026-05 / week-1
Summary: Senior plc traded at 286.00p on Friday, May 8, 2026, at 16:47 BST. A new buyer's remaining scheme claim is 297.85p in cash, not the stale 300p headline, because the 2.15p FY25 final dividend was reserved for hol...
2026-05-10 · 2026-05 / week-1
Why this one now: The disagreement is measurable today, not theoretical. The latest price snapshot put RVI at $39.13 on May 8, 2026, while the last reported NAV was $24.7011 per share on March 4, 2026. Robinhood's own ma...
2026-05-10 · 2026-05 / week-1
Why this one now: It has the cleanest mix of fresh primary evidence, a hard catalyst calendar, visible capital-allocation support, and a valuation gap that still exists even after the stock's recent move.
2026-05-10 · 2026-05 / week-1
Summary: KBR closed at $32.54 on Friday, May 8, 2026. Five days after it reaffirmed full-year guidance, reported $23.2 billion of backlog and options, and fixed the planned Mission Technology Solutions spin for January 4...
2026-05-10 · 2026-05 / week-1
Summary: IHS Holding Ltd. closed at $8.24 in the latest U.S. session, timestamped 2026-05-09 07:15 Singapore time, against MTN Group's signed $8.50 per share cash merger consideration. The spread is only $0.26, or about ...
2026-05-10 · 2026-05 / week-1
Why this one now: It has the cleanest mix of fresh primary evidence, hard dates, board-forced capital return, and a live discount that is still wider than management's own proposed exit path.
2026-05-10 · 2026-05 / week-1
Summary: Destiny Tech100 NYSE: DXYZ was quoted at $54.60 in the latest market snapshot on Friday, May 8, 2026, 7:53 PM EDT, even though the fund's latest official net asset value was only $19.97 per share as of December ...
2026-05-10 · 2026-05 / week-1
Summary: NCR Atleos NYSE: NATL closed at $44.27 on Friday, May 8, 2026, while the signed Brink's transaction was worth $46.88 on the same tape, based on $30.00 cash plus 0.1574 Brink's shares with BCO at $107.22. The raw...
2026-05-10 · 2026-05 / week-1
Summary: Assertio Holdings Nasdaq: ASRT closed at $22.50 on Friday, May 8, 2026, and still traded $22.21 after hours, even though Garda Capital's amended merger price is only $21.80 in cash. That is not a normal merger s...
2026-05-10 · 2026-05 / week-1
Summary: Amaroq closed at 102.5p on Friday, May 8, 2026 even after doubling its revolving credit facility to $70 million, locking in a May 13 results-and-capital-markets update, and winning shareholder approval for the s...
2026-05-10 · 2026-05 / week-1
Summary: Allied Gold Corp. NYSE: AAUC last traded at $29.16 on the cited U.S. quote page for May 7, 2026, while Zijin Mining's signed C$44.00 per share cash acquisition was worth about $32.27 at the same time using a CAD...
2026-05-10 · 2026-05 / week-1
Summary: The AES Corporation NYSE: AES traded at $14.33 against a signed $15.00 per share all-cash acquisition by Global Infrastructure Partners and EQT. The spread says shareholders can afford to say no. AES's own merge...
2026-05-09 · 2026-05 / week-1
Summary: TaskUs NASDAQ: TASK closed at $6.445 in the latest finance snapshot, with a market capitalization of about $567.6 million and a headline 5.7x trailing earnings multiple as of May 9, 2026, 00:15 UTC. The company ...
2026-05-09 · 2026-05 / week-1
Summary: Symbotic NASDAQ: SYM fell to $52.29 after fiscal Q2 results, down 7.34% in the latest market snapshot. The business is not broken: Q2 revenue was $676.5 million, cash plus restricted cash was about $2.0 billion,...
2026-05-09 · 2026-05 / week-1
Summary: Rocket Pharmaceuticals now has an FDA-approved gene therapy, a signed $180 million Priority Review Voucher sale, and company-guided pro forma cash, cash equivalents, and investments of about $322.6 million. The ...
2026-05-09 · 2026-05 / week-1
Summary: Perfect Corp. NYSE: PERF closed at $1.69 on May 8, 2026, while a founder-led consortium has proposed taking the company private at $1.95 per ordinary share. The spread is not clean arbitrage because the proposal...
2026-05-09 · 2026-05 / week-1
Summary: Organon NYSE: OGN last traded at $13.35 on May 8, 2026 at 23:15 UTC, leaving a 4.9% gross spread to Sun Pharma's signed $14.00 all-cash offer. The setup is not a classic "cheap stock" call. It is a merger-spread...